Position in BMY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$121,981
-$50,810 QoQ
Shares Held
2,117
-25.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#2,218
of 2,506 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sherman Asset Management, Inc. holds $1,769,150 across 7 Drug Manufacturers - General names. BMY ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
657 | $788,025 | |
| 2 | JNJ |
Johnson & Johnson
|
989 | $251,176 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
1,523 | $192,415 | |
| 4 | AMGN |
Amgen Inc
|
519 | $187,940 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,116 | $143,406 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
2,117 | $121,981 | |
| 7 | PFE |
Pfizer Inc
|
3,497 | $84,207 |
All Filings in BMY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,981 | 2,117 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $172,791 | 2,849 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $153,675 | 2,849 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $128,489 | 2,849 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $131,880 | 2,849 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $173,760 | 2,849 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $161,818 | 2,861 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||